0001209191-15-083423.txt : 20151203 0001209191-15-083423.hdr.sgml : 20151203 20151203210529 ACCESSION NUMBER: 0001209191-15-083423 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151201 FILED AS OF DATE: 20151203 DATE AS OF CHANGE: 20151203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ULLIAN ELAINE CENTRAL INDEX KEY: 0001190290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 151268713 MAIL ADDRESS: STREET 1: C/O HOLOGIC, INC. CITY: BEDFORD STATE: MA ZIP: 01730 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-01 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001190290 ULLIAN ELAINE C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2015-12-01 4 M 0 22500 59.55 A 27765 D Common Stock 2015-12-01 4 S 0 6289 128.78 D 21476 D Common Stock 2015-12-01 4 S 0 10711 129.77 D 10765 D Common Stock 2015-12-01 4 S 0 5400 130.68 D 5365 D Common Stock 2015-12-01 4 S 0 100 131.38 D 5265 D Stock Option (right to buy) 59.55 2015-12-01 4 M 0 22500 0.00 D 2022-05-31 Common Stock 22500 0 D Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $128.78 (range $128.25 to $129.23). Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $129.77 (range $129.25 to $130.24). Open market sales reported on this line occurred at a weighted average price of $130.68 (range $130.26 to $131.25). Fully vested. Omar White, Attorney-In-Fact 2015-12-03